JP2023143940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023143940A5 JP2023143940A5 JP2023119151A JP2023119151A JP2023143940A5 JP 2023143940 A5 JP2023143940 A5 JP 2023143940A5 JP 2023119151 A JP2023119151 A JP 2023119151A JP 2023119151 A JP2023119151 A JP 2023119151A JP 2023143940 A5 JP2023143940 A5 JP 2023143940A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharma
- subject
- combination
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762501696P | 2017-05-04 | 2017-05-04 | |
| US62/501,696 | 2017-05-04 | ||
| USPCT/US2017/048748 | 2017-08-25 | ||
| PCT/US2017/048748 WO2018039642A1 (en) | 2016-08-26 | 2017-08-25 | Compositions and methods thereof |
| TW106129169 | 2017-08-28 | ||
| TW106129169A TW201815387A (zh) | 2016-08-26 | 2017-08-28 | 組成物及其方法 |
| US201862634162P | 2018-02-22 | 2018-02-22 | |
| US62/634,162 | 2018-02-22 | ||
| US201862636099P | 2018-02-27 | 2018-02-27 | |
| US201862635554P | 2018-02-27 | 2018-02-27 | |
| US62/636,099 | 2018-02-27 | ||
| US62/635,554 | 2018-02-27 | ||
| US201862636171P | 2018-02-28 | 2018-02-28 | |
| US62/636,171 | 2018-02-28 | ||
| JP2019560216A JP7514078B2 (ja) | 2017-05-04 | 2018-05-03 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
| PCT/US2018/030978 WO2018204713A1 (en) | 2017-05-04 | 2018-05-03 | Targeted drug rescue with novel compositions, combinations, and methods thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560216A Division JP7514078B2 (ja) | 2017-05-04 | 2018-05-03 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023143940A JP2023143940A (ja) | 2023-10-06 |
| JP2023143940A5 true JP2023143940A5 (https=) | 2024-10-04 |
Family
ID=65431106
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560216A Active JP7514078B2 (ja) | 2017-05-04 | 2018-05-03 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
| JP2023119151A Pending JP2023143940A (ja) | 2017-05-04 | 2023-07-21 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560216A Active JP7514078B2 (ja) | 2017-05-04 | 2018-05-03 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3618819A4 (https=) |
| JP (2) | JP7514078B2 (https=) |
| KR (2) | KR20200062078A (https=) |
| CN (1) | CN110831584B (https=) |
| AU (2) | AU2018261654A1 (https=) |
| BR (1) | BR112019022902A2 (https=) |
| CA (2) | CA3062452C (https=) |
| IL (1) | IL270326B2 (https=) |
| MA (1) | MA49464A (https=) |
| RU (1) | RU2760558C9 (https=) |
| TW (1) | TWI787260B (https=) |
| WO (1) | WO2018204713A1 (https=) |
| ZA (1) | ZA201908006B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA49464A (fr) * | 2017-05-04 | 2020-04-29 | Exciva GmbH | Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants |
| TW202102219A (zh) * | 2019-03-18 | 2021-01-16 | 美商艾賓爾製藥公司 | 使用氘化右旋美沙芬(dextromethorphan)及奎尼丁(quinidine)治療精神分裂症之負面徵候之方法 |
| JP7400818B2 (ja) * | 2019-06-06 | 2023-12-19 | Jsr株式会社 | 感放射線性樹脂組成物、レジストパターン形成方法及び化合物 |
| KR20240096817A (ko) | 2020-05-19 | 2024-06-26 | 사이빈 아이알엘 리미티드 | 중수소화된 트립타민 유도체 및 사용 방법 |
| CN116473077B (zh) * | 2023-05-08 | 2025-04-11 | 广东方中高新材料有限公司 | 一种n,n配位的镓配合物抗菌剂的合成和应用 |
| CN116473073A (zh) * | 2023-05-08 | 2023-07-25 | 广东方中高新材料有限公司 | 一种含镓配合物的吡唑醚菌酯增效悬浮制剂及其制备方法 |
| CN119432479B (zh) * | 2023-08-04 | 2025-10-03 | 中国石油天然气股份有限公司 | 柴油机润滑油组合物及其制备方法 |
| CN120987847B (zh) * | 2024-11-29 | 2026-02-17 | 江苏恩华药业股份有限公司 | 一种氢溴酸右美沙芬的制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4241065A (en) * | 1979-07-02 | 1980-12-23 | E. I. Du Pont De Nemours And Company | Fluoro analogs of hydrocodone and oxycodone useful as analgesics, narcotic antagonists or both |
| US4950658A (en) * | 1988-12-06 | 1990-08-21 | Board Of Trustees Of Southern Illinois Univ. | Method of medical treatment of Alzheimer's disease |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US6207674B1 (en) * | 1999-12-22 | 2001-03-27 | Richard A. Smith | Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
| US6335371B1 (en) * | 2000-11-28 | 2002-01-01 | Orion Corporation | Method for inducing cognition enhancement |
| TWI326214B (en) * | 2002-07-17 | 2010-06-21 | Avanir Pharmaceuticals Inc | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| US20070099947A1 (en) * | 2005-11-03 | 2007-05-03 | Alkermes, Inc. | Methods and compositions for the treatment of brain reward system disorders by combination therapy |
| CA2641392A1 (en) | 2006-02-03 | 2007-08-16 | Avanir Pharmaceuticals | Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders |
| US7973049B2 (en) * | 2007-05-01 | 2011-07-05 | Concert Pharmaceuticals Inc. | Morphinan compounds |
| EP2162135A4 (en) * | 2007-05-21 | 2012-02-22 | Reviva Pharmaceuticals Inc | COMPOSITIONS, SYNTHESIS AND METHOD FOR THE APPLICATION OF ATTAINED CHINOLINONE-BASED ANTIPSYCHOTICS |
| US8017623B2 (en) * | 2008-07-03 | 2011-09-13 | Trinity Laboratories, Inc. | Dextromethorphan hydrochloride |
| US9737531B2 (en) * | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| EP2964022B1 (en) * | 2013-03-07 | 2019-11-06 | Mindlab LLC | Pain medicine combination and uses thereof |
| AU2014232869A1 (en) * | 2013-03-15 | 2015-10-08 | Patrizia Fanara | Methods for monitoring the effects of an agent in sujects with motoneuron disease with dementia |
| CN117427077A (zh) * | 2014-09-14 | 2024-01-23 | 阿瓦尼尔制药股份有限公司 | 用于治疗痴呆中的激越行为的包含右美沙芬化合物和奎尼丁的药物组合物 |
| US11103499B2 (en) * | 2016-08-26 | 2021-08-31 | EXCIVA (UG) (haftungsbeschränkt) | Compositions and methods thereof |
| MA49464A (fr) * | 2017-05-04 | 2020-04-29 | Exciva GmbH | Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants |
-
2018
- 2018-05-03 MA MA049464A patent/MA49464A/fr unknown
- 2018-05-03 BR BR112019022902A patent/BR112019022902A2/pt not_active Application Discontinuation
- 2018-05-03 KR KR1020197035796A patent/KR20200062078A/ko not_active Ceased
- 2018-05-03 RU RU2019137004A patent/RU2760558C9/ru active
- 2018-05-03 EP EP18794381.6A patent/EP3618819A4/en active Pending
- 2018-05-03 CA CA3062452A patent/CA3062452C/en active Active
- 2018-05-03 WO PCT/US2018/030978 patent/WO2018204713A1/en not_active Ceased
- 2018-05-03 CN CN201880037396.3A patent/CN110831584B/zh active Active
- 2018-05-03 JP JP2019560216A patent/JP7514078B2/ja active Active
- 2018-05-03 KR KR1020217033764A patent/KR102444803B1/ko active Active
- 2018-05-03 AU AU2018261654A patent/AU2018261654A1/en not_active Abandoned
- 2018-05-03 CA CA3138116A patent/CA3138116A1/en active Pending
- 2018-05-04 TW TW107115320A patent/TWI787260B/zh active
-
2019
- 2019-10-31 IL IL270326A patent/IL270326B2/en unknown
- 2019-12-02 ZA ZA2019/08006A patent/ZA201908006B/en unknown
-
2021
- 2021-08-13 AU AU2021215274A patent/AU2021215274B2/en active Active
-
2023
- 2023-07-21 JP JP2023119151A patent/JP2023143940A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023143940A5 (https=) | ||
| JP2025013344A5 (https=) | ||
| JP6406713B2 (ja) | 低用量薬剤によるうつ病および他の疾患の処置 | |
| JP5543200B2 (ja) | ３−（３−ジメチルアミノ−１−エチル−２−メチル−プロピル）−フェノール及びｎｓａｉｄ含む医薬の組合せ | |
| JP2008538741A (ja) | 鬱病の治療用及び／又は予防用の医薬組成物 | |
| JP2004526788A5 (https=) | ||
| CN101431990B (zh) | 包含3-（3-二甲基氨基-1-乙基-2-甲基-丙基）-酚和对乙酰氨基酚的药物结合 | |
| JP2009526821A (ja) | 注意欠陥多動性障害治療用の新規な医薬組成物 | |
| JP2014062126A5 (https=) | ||
| JP2009541443A5 (https=) | ||
| JP2002226401A (ja) | うつ病の併用療法 | |
| RU2404771C3 (ru) | Комбинации, содержащие антимускариновые средства и бета-адренергические агонисты | |
| WO2004071431A2 (en) | Method and composition for treating neurodegenerative disorders | |
| JP2008521827A5 (https=) | ||
| JP2009527525A (ja) | 尿失禁治療用のベンゾイミダゾロン誘導体 | |
| JP2002515435A (ja) | 鬱病処置のための組合せ治療 | |
| CN116209657A (zh) | 用于精神障碍或增强的2-氨基茚满化合物 | |
| JP2004532828A5 (https=) | ||
| MXPA02004410A (es) | Tratamiento de combinacion para la ansiedad y la depresion. | |
| MX2008000249A (es) | Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos. | |
| JP2025163212A5 (https=) | ||
| JP2021530488A (ja) | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール | |
| JPH02138214A (ja) | 不安を治療する方法 | |
| JP7208139B2 (ja) | 双極性障害の予防、軽減又は治療のためのカルバメート化合物の使用 | |
| JP2015510893A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 |